OncoCyte Insider Trades

-0.25 (-4.80 %)
(As of 04/13/2021 12:00 AM ET)
Today's Range
Now: $4.96
50-Day Range
MA: $2.38
52-Week Range
Now: $4.96
Volume472,927 shs
Average Volume1.39 million shs
Market Capitalization$441.01 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

OncoCyte (NYSEAMERICAN:OCX) Insider Buying and Selling Activity

Insider Ownership Percentage: 5.64%
Insider Buying (Last 12 Months): $7,472,697.60
Insider Selling (Last 12 Months): $15,370.92

Insider Buying and Selling by Quarter

OncoCyte (NYSEAMERICAN OCX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/19/2021Ronald Asbury AndrewsCEOBuy11,000$4.79$52,690.00113,698  
1/20/2021Broadwood Partners, L.P.Major ShareholderBuy1,460,280$3.42$4,994,157.60  
12/23/2020Alfred D KingsleyDirectorSell900$2.55$2,295.00319,740  
12/21/2020Alfred D KingsleyDirectorSell5,148$2.54$13,075.92350,787  
8/3/2020Albert P ParkerCOOBuy5,000$1.33$6,650.005,000  
8/3/2020Mitchell S LevineCFOBuy10,000$1.32$13,200.0036,579  
8/3/2020Ronald Asbury AndrewsCEOBuy40,000$1.35$54,000.00102,698  
4/24/2020Broadwood Partners, L.P.Major ShareholderBuy1,050,000$2.24$2,352,000.00  
3/30/2020Ronald Asbury AndrewsCEOBuy27,216$2.26$61,508.1644,698  
1/2/2020Broadwood Partners, L.P.Major ShareholderBuy1,391,466$2.16$3,005,566.56  
11/13/2019Broadwood Partners, L.P.Major ShareholderBuy1,176,471$1.70$2,000,000.70  
9/17/2019Andrew ArnoDirectorBuy50,000$2.16$108,000.00
9/12/2019Mitchell S LevineCFOBuy10,000$2.01$20,100.00
9/11/2019Broadwood Partners, L.P.Major ShareholderBuy2,000,000$1.66$3,320,000.00
9/11/2019Thomas Alex VetterCEOBuy11,000$9.58$105,380.00
7/5/2019Biotime IncMajor ShareholderSell2,250,000$2.00$4,500,000.00  
7/2/2019Broadwood Partners, L.P.Major ShareholderBuy1,000,000$2.00$2,000,000.00  
2/8/2019Broadwood Partners, L.P.Major ShareholderBuy533,333$3.75$1,999,998.75  
3/28/2018Broadwood Partners, L.P.Major ShareholderBuy3,968,254$1.26$5,000,000.04  
(Data available from 1/1/2013 forward)
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.